Investigation of the efficacy and safety of eltrombopag to correct thrombocytopenia in moderate to severe dengue patients - a phase II randomized controlled clinical trial.

Sajib Chakraborty,Mohammad Sayem,Tonmoy Das,Chowdhury Tamanna Tabassum,Mousumi Sanyal,Md.Robed Amin,Piyal Saha,Saruar Alam,Ahmedul Kabir,Bartholomia Keya Byapari,A.H.M Nurun Nabi

doi:10.1016/j.eclinm.2020.100624

Investigation of the efficacy and safety of eltrombopag to correct thrombocytopenia in moderate to severe dengue patients - a phase II randomized controlled clinical trial.

Sajib Chakraborty, Mohammad Sayem + Show 9 more

Open Access

PDF Available

https://doi.org/10.1016/j.eclinm.2020.100624

Copy DOI

Export

Save

Cite

Journal: EClinicalMedicine	Publication Date: Nov 21, 2020
Citations: 10	License type: cc-by-nc-nd

Affiliation: University of Dhaka, Dhaka Medical College and Hospital, Square Hospitals

#Dose Of Eltrombopag #Efficacy Of Eltrombopag #Platelet Count #Dengue Hemorrhagic Fever #Dengue Hemorrhagic Fever Patients #Absolute Immature Platelet Count #Immature Platelet Fraction #Lower Normal Limit #Thrombopoietin Receptor Agonist #Group-1 Patients

Abstract
Full-Text PDF
Similar Papers

Abstract

Listen

Investigation of the efficacy and safety of eltrombopag to correct thrombocytopenia in moderate to severe dengue patients - a phase II randomized controlled clinical trial.

Full Text

Published Version (Free)

View/Download pdf

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: EClinicalMedicine

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

Investigation of the efficacy and safety of eltrombopag to correct thrombocytopenia in moderate to severe dengue patients - a phase II randomized controlled clinical trial.